未登录Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIsCML接受第二代TKI治疗后达到MR4.5及TKI停药资格的早期预测因子
Ono, Takaaki; Okada, Takashi; Takahashi, Naoto; Minami, Yosuke; Nakaseko, Chiaki; Iriyama, Noriyoshi; Fujimaki, Katsumichi; Kakihana, Kazuhiko; Ogasawara, Yoji; Okada, Masaya; Tauchi, Tetsuzo; Atsuta, Yoshiko; Ohtake, Shigeki; Miyamoto, Toshihiro; Ohnishi, Kazunori; Sakaida, Emiko; Fujisawa, Shin; Kobayashi, Yukio; Kiyoi, Hitoshi; Miyazaki, Yasushi; Matsumura, Itaru .png)
分享.png)
收藏Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan日本复发或难治性慢性淋巴细胞白血病患者接受维奈克拉治疗后的可测量残留病灶Matsui, Hirotaka; Takizawa, Jun; Kojima, Kensuke; Tauchi, Tetsuzo; Ikeda, Chiaki; Aruga, Yu; Sakamoto, Hiroki; Takenaka, Risa; Park, Jinhaeng; Morita, Tetsuo; Matsushita, Hiromichi; Suzuki, Ritsuro 分享 收藏 Nilotinib vs dasatinib in achieving MR 4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 studyMatsumura, Itaru; Ohtake, Shigeki; Atsuta, Yoshiko; Kurata, Mio; Minami, Yosuke; Takahashi, Naoto; Nakaseko, Chiaki; Iriyama, Noriyoshi; Fujimaki, Katsumichi; Kakihana, Kazuhiko; Ogasawara, Yoji; Ono, Takaaki; Okada, Masaya; Tauchi, Tetsuzo; Miyamoto, Toshihiro; Ohnishi, Kazunori; Sakaida, Emiko; Fujisawa, Shin; Kobayashi, Yukio; Asou, Norio; Naoe, Tomoki; Kiyoi, Hitoshi; Miyazaki, Yasushi; Japan Adult Leukemia Study Group, for the Japan Adult Leukemia Study Group 分享 收藏 Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trialsCortes, Jorge E.; Dombret, Herve; Merchant, Akil; Tauchi, Tetsuzo; DiRienzo, Christine G.; Sleight, Barbara; Zhang, Xiaoxi; Leip, Eric P.; Shaik, Naveed; Bell, Timothy; Chan, Geoffrey; Sekeres, Mikkael A. 分享 收藏 Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1造血干细胞移植治疗1型活化phosphatidylinositol-3-OH激酶 δ 综合征患者的进行性联合免疫缺陷和淋巴增殖Okano, Tsubasa; Imai, Kohsuke; Tsujita, Yuki; Mitsuiki, Noriko; Yoshida, Kenichi; Kamae, Chikako; Honma, Kenichi; Mitsui-Sekinaka, Kanako; Sekinaka, Yujin; Kato, Tamaki; Hanabusa, Katsuyuki; Endo, Eri; Takashima, Takehiro; Hiroki, Haruka; Yeh, Tzu-Wen; Tanaka, Keisuke; Nagahori, Masakazu; Tsuge, Ikuya; Bando, Yuki; Iwasaki, Fuminori; Shikama, Yoshiaki; Inoue, Masami; Kimoto, Tomiko; Moriguchi, Naohiko; Yuza, Yuki; Kaneko, Takashi; Suzuki, Kyoko; Matsubara, Tomoyo; Maruo, Yoshihiro; Kunitsu, Tomoaki; Waragai, Tomoko; Sano, Hideki; Hashimoto, Yuko; Tasaki, Kazuhiro; Suzuki, Osamu; Shirakawa, Toshihiko; Kato, Motohiro; Uchiyama, Toru; Ishimura, Masataka; Tauchi, Tetsuzo; Yagasaki, Hiroshi; Jou, Shiann-Tarng; Yu, Hsin-Hui; Kanegane, Hirokazu; Kracker, Sven; Durandy, Anne; Kojima, Daiei; Muramatsu, Hideki; Wada, Taizo; Inoue, Yuzaburo; Takada, Hidetoshi; Kojima, Seiji; Ogawa, Seishi; Ohara, Osamu; Nonoyama, Shigeaki; Morio, Tomohiro 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemiaBcr-abl调节费城染色体阳性白血病中TNF相关凋亡诱导配体 (TRAIL) 的死亡受体表达Kuroda, I.; Inukai, T.; Zhang, X.; Kikuchi, J.; Furukawa, Y.; Nemoto, A.; Akahane, K.; Hirose, K.; Honna-Oshiro, H.; Goi, K.; Kagami, K.; Yagita, H.; Tauchi, T.; Maeda, Y.; Sugita, K. 分享 收藏 A novel heat shock protein 90 inhibitor, NVP-AUY922, enhances the antitumor effect of imatinib via autophagy on imatinib-resistant CML cellsOsato, Yoichi; Yokoyama, Tomohisa; Hayabe, Hiroko; Miyasato, Akime; Akashi, Takao; Komatsu, Seiichiro; Tauchi, Tetsuzo; Ohyashiki, Kazuma 分享 收藏 EGFR-targeted gold liposome for molecular imaging and therapy on NSCLC cellsYokoyama, Tomohisa; Osato, Yoichi; Miyazawa, Keisuke; Miyasato, Akime; Hayabe, Hiroko; Nomura, Masaharu; Gotoh, Noriko; Itoi, Takao; Tauchi, Tetsuzo; Ikeda, Norihiko; Ohyashiki, Kazuma 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: Does body weight matter?Kanda, Yoshinobu; Okamoto, Shinichiro; Tauchi, Tetsuzo; Kizaki, Masahiro; Inokuchi, Koiti; Yabe, Mariko; Yokoyama, Kenji; Ito, Yoshikazu; Kimura, Yukihiko; Higashihara, Masaaki; Bessho, Masami; Ando, Kiyoshi; Chiba, Shigeru; Kurokawa, Mineo; Oshimi, Kazuo; Dan, Kazuo; Ohyashiki, Kazuma; Ikeda, Yasuo 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
